Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability, antiretroviral activity, pharmacokinetics,
and pharmacodynamics of an intravenous formulation of deferiprone in HIV-infected subjects.